These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17390569)

  • 1. ADHD black box warning: how concerned should we be?
    Cruz R; Kutscher EC
    S D Med; 2007 Feb; 60(2):63, 65. PubMed ID: 17390569
    [No Abstract]   [Full Text] [Related]  

  • 2. [Medication for ADHD and the risk of cardiovascular mortality].
    Langendijk PN; Wilde AA
    Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1713-4. PubMed ID: 16924941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular safety of ADHD medications: rationale for and design of an investigator-initiated observational study.
    Hennessy S; Schelleman H; Daniel GW; Bilker WB; Kimmel SE; Guevara J; Cziraky MJ; Strom BL
    Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):934-41. PubMed ID: 20623519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adderall and other drugs for attention-deficit/hyperactivity disorder.
    Med Lett Drugs Ther; 1994 Nov; 36(936):109-10. PubMed ID: 7968783
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety of stimulant treatment in attention deficit hyperactivity disorder: part II.
    Merkel RL
    Expert Opin Drug Saf; 2010 Nov; 9(6):917-35. PubMed ID: 20615078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ECGs before stimulants in children.
    Med Lett Drugs Ther; 2008 Jul; 50(1291):60. PubMed ID: 18654112
    [No Abstract]   [Full Text] [Related]  

  • 7. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of methylphenidate.
    Daniels SR
    J Pediatr; 2009 Jul; 155(1):A3. PubMed ID: 19559283
    [No Abstract]   [Full Text] [Related]  

  • 9. ADHD drugs and cardiovascular risk.
    Rappley MD; Moore JW; Dokken D
    N Engl J Med; 2006 May; 354(21):2296-8; author reply 2296-8. PubMed ID: 16729375
    [No Abstract]   [Full Text] [Related]  

  • 10. A clinican's guide to adult attention-deficit hyperactivity disorder.
    Modesto-Lowe V; Meyer A; Soovajian V
    Conn Med; 2012 Oct; 76(9):517-23. PubMed ID: 23155670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADHD drugs and cardiovascular risk.
    Anders T; Sharfstein S
    N Engl J Med; 2006 May; 354(21):2296-8; author reply 2296-8. PubMed ID: 16723628
    [No Abstract]   [Full Text] [Related]  

  • 12. To box OR NOT TO box.
    Newstadt M
    J Ky Med Assoc; 2006 Aug; 104(8):344-5. PubMed ID: 16939037
    [No Abstract]   [Full Text] [Related]  

  • 13. Medications for attention deficit hyperactivity disorder: cardiovascular concerns.
    Wooltorton E
    CMAJ; 2006 Jul; 175(1):29. PubMed ID: 16772535
    [No Abstract]   [Full Text] [Related]  

  • 14. Medications for adolescents with attention-deficit/hyperactivity disorder.
    Soileau EJ
    Adolesc Med State Art Rev; 2008 Aug; 19(2):254-67, viii-ix. PubMed ID: 18822831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adderall, the atypicals, and weight gain.
    Horrigan JP; Barnhill LJ; Kohli RR
    J Am Acad Child Adolesc Psychiatry; 2001 Jun; 40(6):620. PubMed ID: 11392337
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacology of adult ADHD with stimulants.
    Spencer TJ
    CNS Spectr; 2007 Apr; 12(4 Suppl 6):8-11. PubMed ID: 17715564
    [No Abstract]   [Full Text] [Related]  

  • 18. Adderall and seizures.
    Thomas S; Upadhyaya H
    J Am Acad Child Adolesc Psychiatry; 2002 Apr; 41(4):365. PubMed ID: 11931590
    [No Abstract]   [Full Text] [Related]  

  • 19. ADHD drugs and cardiovascular risk.
    Nissen SE
    N Engl J Med; 2006 Apr; 354(14):1445-8. PubMed ID: 16549404
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder.
    Hammerness P; Wilens T; Mick E; Spencer T; Doyle R; McCreary M; Becker J; Biederman J
    J Pediatr; 2009 Jul; 155(1):84-9, 89.e1. PubMed ID: 19394037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.